In a 6-hydroxydopamine-lesioned model of PD, β-arrestin2 overexpression attenuates LID-associated symptoms and decreases D1R activation and the levels of D1R-associated markers FosB, ERK1/2 phosphorylation, and DARPP-32144,149. Here, DRD1 is linked to Parkinson disease.